{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:12:36Z","timestamp":1769724756313,"version":"3.49.0"},"reference-count":12,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T00:00:00Z","timestamp":1134345600000},"content-version":"vor","delay-in-days":3389,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1996,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>. To report the outcome of 124 claims of chronic arthropathy associated with rubella vaccine submitted to the National Vaccine Injury Compensation Program.<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>. Medical records and testimony were reviewed separately by physicians and Special Masters to determine the clinical diagnosis and eligibility for compensation under the Program.<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. Among the 124 subjects with chronic arthropathy, the onset occurred between 1 week and 6 weeks after the rubella vaccination in 72, and &lt;1 week or &gt;6 weeks after the vaccination in 52. Various conditions developed in the 2 onset groups (1\u20136 weeks postvaccination, &lt;1 week or &gt;6 weeks postvaccination), including, respectively, unspecified arthritis (n = 29, n = 1), specified arthritis (n = 11, n = 19), arthralgia (n = 24, n = 7), fibromyalgia (n = 4, n = 11), and multiple symptoms with minimal arthralgia or myalgia (n = 4, n = 14). Concordance of medical recommendations by Program physicians and Special Masters' decisions in 56 completed claims was 91%, with awards mainly to patients with chronic unspecified arthritis and arthralgia.<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>. The Program and the US Court of Federal Claims have accepted a causal relationship between currently used rubella vaccine in the US and some chronic arthropathy with an onset between 1 week and 6 weeks after vaccine administration.<\/jats:p>","DOI":"10.1002\/art.1780390913","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T12:01:54Z","timestamp":1171454514000},"page":"1529-1534","source":"Crossref","is-referenced-by-count":41,"title":["Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines. A review of 124 claims submitted to the national vaccine injury compensation program"],"prefix":"10.1002","volume":"39","author":[{"given":"Robert E.","family":"Weibel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Benor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"e_1_2_1_2_2","unstructured":"Public Law 99\u2010660 National Childhood Vaccine Injury Act of 1986 codified as Sec. 2111 et seq. of the Public Health Service Act. [42 U.S.C. 300aa\u201011 et seq.]"},{"key":"e_1_2_1_3_2","volume-title":"Adverse Effects of Pertussis and Rubella Vaccines","author":"Howson CP","year":"1991"},{"key":"e_1_2_1_4_2","unstructured":"Section 2111(c)(1)(C) of the Public Health Service Act 42 U.S.C. 300aa\u201011(c)(1)(C)"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.222.7.805"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196903272801302"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.2.110"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.3.606"},{"key":"e_1_2_1_9_2","first-page":"36878","article-title":"Revision of the Vaccine Injury Table","volume":"57","author":"National Vaccine Injury Compensation Program","year":"1992","journal-title":"Federal Register"},{"key":"e_1_2_1_10_2","volume-title":"Revision of the Vaccine Injury Table","author":"National Vaccine Injury Compensation Program","year":"1995"},{"key":"e_1_2_1_10_3","first-page":"7678","volume":"60","journal-title":"Revision of the Vaccine Injury Table."},{"key":"e_1_2_1_11_2","unstructured":"Section 2121 (a) of the Public Health Service Act 42 U.S.C 300aa\u201021 (a)"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.507"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780390913","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780390913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T01:19:42Z","timestamp":1700702382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780390913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1996,9]]}},"alternative-id":["10.1002\/art.1780390913"],"URL":"https:\/\/doi.org\/10.1002\/art.1780390913","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,9]]}}}